2013 International Pharmaceutical Innovation Forum has successfully held in Marriott Hotel in Beijing on 18th October. This forum was co-hosted by China Chamber of International Commerce（CCOIC）、China Pharmaceutical Industry Research and Development Association (SINO-PhIRDA)、Drug Information Association (DIA)、China Health Insurance Research Association (CHIRA)、Beijing Municipal Health Bureau、Beijing Food and Drug Administration.

Song Ruilin, Executive President of SINO-PhIRDA hosted the meeting in the morning. This forum has invited senior officials from NDRC, MIIT, MOHRSS, CFDA and related governments, including: Sun Xianze, Member of Party Committee in CFDA; Xu Jiaqi, Inspector-General of Department of Drugs and Cosmetics Registration in CFDA; Zheng Hong, Director-General of Department of National Drug Policy and Essential Medicine System in NHFPC; Yao Hong, Director-General of Medical Insurance Department of Ministry of Human Resource of Social Security; Guo Jianying, Vice Inspector-General of Price Department of NDRC; Cong Luoluo, Vice Director-General of Beijing Food and Drug Administration; Lu Fengxia, Director of Evaluation Center of Drug Pricing National Development and Reform Commission; Fang Laiying, Secretary of Party Leadership Group and Director of Beijing Municipal Health Bureau; Li Maozhong, Vice Director –General of Department of Drugs and Cosmetics Registration in CFDA; Zhang Jun, Director of Department of Consumer Products in MIIT; Zhang Qingkui, Former Director-General of Pharmaceutical and Biotech Examination Department in SIPO; Zhao Hui, Vice Director of Human Resource and Social Security Department of Jiangsu and Geng Chengliang, Director of Human Resource and Social Security Department of Qingdao.

Foreign representatives: Marcin Ko?akowski, Vice-president for Medicinal Products, Office for Registration of Medicinal Products, Medical Devices and Biocidal Products; Clive Allcorn, the British Consulate-General in Shanghai, Jennifer Osika , Assistant Vice President at PhRMA; Timothy R. Franson, Principal in FaegreBD Consulting's Health and Biosciences Sector; Andrew Jenner, Director of IFPMA;  Dave Tapolczay, CEO of Medical Research Council Technology; Kirk Brown, Principal of WorLDiscoveries in University of Western Ontario in Canada and J.Berlin, Executive Editor in PharmAsia have participated in this forum.

This forum has attracted attention from pharmaceutical enterprises all around the world and more than 400 attendees from domestics and multinational companies, industry associations, academic agencies and government have attended this event.

The plenary Meeting

Hosted by Song Ruilin, Executive President of SINO-PhIRDA

Cong Luoluo,Vice Director-General of Beijing Food and Drug Administration, read the letter from Sang Guowei ,Vice Chairman of the Standing Committee of the 11th National People’s Congress.

Addressed by Sun Xianze, Member of Party Committee in CFDA

Addressed by Lin Shunjie, Secretary-General of CCOIC.

Addressed by Yan Xijun, SINO-PhIRDA Chairman of the Board in 2013-2014, Tianjin Tasly Group Co., Ltd

Addressed by Fang Laiying, Secretary of Party Leadership Group and Director of Beijing Municipal Health Bureau

Speech by Xu Jiaqi, Inspector-General of Department of Drugs and Cosmetics Registration in CFDA

Speech by Marcin Ko akowsk，Vice-president for Medicinal Products, Office for Registration of Medicinal Products, Medical Devices and Biocidal Products in Poland

Speech by Zheng Hong, Director-General of Department of National Drug Policy and Essential Medicine System in NHFPC

Speech by Timothy R. Franson, Principal in FaegreBD Consulting's Health and Biosciences Sector